The effect of Ozempic and its sister drugs continues to confound users and researchers alike. The medications, which include Ozempic, Wegovy, and Mounjaro, have been around since 2017, but have exploded in popularity over the past couple of years. The drugs, which belong to a class of medications called semaglutides, were originally designed and tested for Type 2 diabetes. Now, at least one has been approved for obesity, and as more users put the drugs to the test, researchers are finding ever-increasing ways they influence our bodies.
